Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 16 | 2019 | 204 | 3.220 |
Why?
|
| Brain | 14 | 2019 | 202 | 3.210 |
Why?
|
| Cognition | 13 | 2019 | 220 | 2.500 |
Why?
|
| Cognitive Dysfunction | 9 | 2025 | 165 | 2.420 |
Why?
|
| Alzheimer Disease | 15 | 2019 | 250 | 2.240 |
Why?
|
| Dementia | 6 | 2018 | 73 | 1.820 |
Why?
|
| Aged, 80 and over | 25 | 2025 | 567 | 1.720 |
Why?
|
| Longitudinal Studies | 17 | 2025 | 260 | 1.540 |
Why?
|
| Female | 27 | 2025 | 1724 | 1.410 |
Why?
|
| Male | 27 | 2025 | 1860 | 1.410 |
Why?
|
| Cognition Disorders | 9 | 2017 | 175 | 1.390 |
Why?
|
| Humans | 30 | 2025 | 2957 | 1.310 |
Why?
|
| Aged | 23 | 2025 | 956 | 1.300 |
Why?
|
| DNA-Binding Proteins | 7 | 2019 | 69 | 1.130 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 34 | 1.100 |
Why?
|
| Health Literacy | 2 | 2017 | 15 | 0.980 |
Why?
|
| Neuropsychological Tests | 12 | 2019 | 238 | 0.910 |
Why?
|
| Lewy Bodies | 5 | 2019 | 37 | 0.800 |
Why?
|
| Disease Progression | 4 | 2019 | 99 | 0.780 |
Why?
|
| Perception | 2 | 2019 | 21 | 0.710 |
Why?
|
| Memory, Episodic | 2 | 2019 | 22 | 0.710 |
Why?
|
| Decision Making | 2 | 2018 | 19 | 0.660 |
Why?
|
| Hippocampus | 3 | 2019 | 41 | 0.650 |
Why?
|
| Neurofibrillary Tangles | 3 | 2017 | 24 | 0.630 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 9 | 0.610 |
Why?
|
| Independent Living | 3 | 2025 | 29 | 0.600 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 23 | 0.570 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2015 | 17 | 0.570 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 9 | 0.550 |
Why?
|
| Learning | 1 | 2018 | 20 | 0.540 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 9 | 0.540 |
Why?
|
| Cognitive Aging | 1 | 2018 | 27 | 0.540 |
Why?
|
| Literacy | 1 | 2017 | 4 | 0.520 |
Why?
|
| Ambulatory Care | 1 | 2017 | 9 | 0.520 |
Why?
|
| Chronic Disease | 1 | 2017 | 28 | 0.520 |
Why?
|
| Neuropathology | 1 | 2017 | 16 | 0.510 |
Why?
|
| Hospitalization | 1 | 2017 | 49 | 0.510 |
Why?
|
| Agnosia | 1 | 2016 | 3 | 0.490 |
Why?
|
| Plaque, Amyloid | 2 | 2015 | 18 | 0.480 |
Why?
|
| Cohort Studies | 9 | 2018 | 233 | 0.450 |
Why?
|
| Educational Status | 4 | 2017 | 41 | 0.390 |
Why?
|
| Autopsy | 5 | 2019 | 39 | 0.370 |
Why?
|
| Apolipoprotein E4 | 2 | 2025 | 76 | 0.320 |
Why?
|
| Brain Infarction | 3 | 2018 | 20 | 0.300 |
Why?
|
| Sclerosis | 3 | 2019 | 25 | 0.300 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 51 | 0.300 |
Why?
|
| Memory | 3 | 2018 | 48 | 0.270 |
Why?
|
| Risk Factors | 3 | 2017 | 275 | 0.260 |
Why?
|
| Amyloid beta-Peptides | 2 | 2017 | 28 | 0.250 |
Why?
|
| Middle Aged | 5 | 2017 | 792 | 0.200 |
Why?
|
| Motor Activity | 2 | 2015 | 53 | 0.200 |
Why?
|
| Risk | 3 | 2018 | 44 | 0.190 |
Why?
|
| Chicago | 2 | 2025 | 160 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 147 | 0.180 |
Why?
|
| Lewy Body Disease | 2 | 2018 | 13 | 0.160 |
Why?
|
| Comorbidity | 2 | 2018 | 49 | 0.160 |
Why?
|
| Awareness | 2 | 2016 | 10 | 0.150 |
Why?
|
| Sex Factors | 2 | 2016 | 72 | 0.140 |
Why?
|
| Depression | 2 | 2016 | 59 | 0.140 |
Why?
|
| Cerebral Infarction | 2 | 2015 | 18 | 0.140 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 6 | 0.140 |
Why?
|
| RNA, Messenger | 1 | 2017 | 59 | 0.130 |
Why?
|
| Gene Expression | 1 | 2017 | 45 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2017 | 44 | 0.130 |
Why?
|
| Illinois | 1 | 2017 | 22 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2017 | 19 | 0.130 |
Why?
|
| Prognosis | 1 | 2017 | 39 | 0.130 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2016 | 12 | 0.120 |
Why?
|
| Fetus | 1 | 2016 | 4 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 46 | 0.120 |
Why?
|
| Age Factors | 1 | 2016 | 89 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 46 | 0.120 |
Why?
|
| Brain Chemistry | 1 | 2016 | 11 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 43 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 13 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2015 | 7 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2015 | 33 | 0.110 |
Why?
|
| Personality | 1 | 2015 | 8 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 12 | 0.110 |
Why?
|
| Quality of Life | 1 | 2015 | 39 | 0.110 |
Why?
|
| Knowledge | 1 | 2010 | 3 | 0.080 |
Why?
|
| Language | 1 | 2010 | 12 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 97 | 0.070 |
Why?
|
| Logistic Models | 2 | 2016 | 60 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2025 | 11 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2025 | 11 | 0.060 |
Why?
|
| tau Proteins | 1 | 2025 | 18 | 0.060 |
Why?
|
| Biomarkers | 1 | 2025 | 101 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2025 | 203 | 0.050 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 8 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 10 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 77 | 0.030 |
Why?
|
| Arteriolosclerosis | 1 | 2016 | 4 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 34 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 6 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 5 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 7 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2016 | 10 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 9 | 0.030 |
Why?
|
| Brain Stem | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 28 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 18 | 0.030 |
Why?
|
| Self Report | 1 | 2015 | 20 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 38 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 24 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 85 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 65 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 7 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 48 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 5 | 0.030 |
Why?
|
| Life Change Events | 1 | 2014 | 10 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2015 | 51 | 0.030 |
Why?
|
| Mental Recall | 1 | 2014 | 14 | 0.030 |
Why?
|
| Loneliness | 1 | 2014 | 20 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2014 | 24 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 208 | 0.030 |
Why?
|
| Adult | 1 | 2015 | 794 | 0.020 |
Why?
|
| Causality | 1 | 2012 | 6 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 8 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2012 | 6 | 0.020 |
Why?
|
| Life Style | 1 | 2012 | 19 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 28 | 0.020 |
Why?
|
| Exercise | 1 | 2012 | 33 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 64 | 0.020 |
Why?
|